EMA recommends Covid-19 Vaccine AstraZeneca for authorisation in the EU

The European Medicines Agency (EMA) has recommended granting a conditional marketing authorisation for Covid-19 Vaccine AstraZeneca.

This is the third Covid-19 vaccine to be approved by the European Commission.

EMA's evaluation of the vaccine has shown that it meets the EU's requirements for safety, efficacy, quality and manufacturing. 



Tags for this page: